|
|
eLetters is an online forum for ongoing
peer review. To submit an eLetter please go to the article you wish
to respond to and click on the link that reads
"eLetters: Submit a Response." Submission of
eLetters are open to all health care professionals
and experts in related fields.
eLetters to:
-
- ARTICLE:
Steven P. Conway, Susan P. Wolfe, Keith G. Brownlee, Helen White, Brian Oldroyd, John G. Truscott, Julia M. Harvey, and Martin J. Shearer
- Vitamin K Status Among Children With Cystic Fibrosis and Its Relationship to Bone Mineral Density and Bone Turnover
Pediatrics 2005; 115: 1325-1331
[Abstract]
[Full text]
[PDF]
|
|
eLetters published:
-
Vitamin K or Vitamin E: more reason to screen newborns for cystic fibrosis
- Dennis T Costakos, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
(23 September 2005)
|
Vitamin K or Vitamin E: more reason to screen newborns for cystic fibrosis |
23 September 2005 |
|
|
Dennis T Costakos, neonatologist Mayo health System (Lacrosse Wisconsin )and, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
Send letter to journal:
Re: Vitamin K or Vitamin E: more reason to screen newborns for cystic fibrosis
costakos.dennis{at}mayo.edu Dennis T Costakos, et al.
|
Can the authors comment on whether newborn screening for Cystic
fibrosis is occurring in the United Kingdom, on if so, describe the
screening process? Can the authors comment on timing of diagnosis and
Vitamin K status? What about Vitamin K status and Cognitive development?
Why do I ask?
In the United states, some states screen newborns for Cystic fibrosis on
the basis of a randomized, controlled trial showing nutitional and
cognitive benefits for screened newborns (early diagnosis) compared to
traditionally diagnosed children (average age 3 to 4 years of age).Good
evidence for this includes the results of Koscik, RL et al. suugest that
prevention of prolonged malnutrition by early diagnosis and nutritional
therapy, particularly minimizing Vitamin e deficiency, is associated with
better cognitive function.Vitamin E deficiency (alpha-tocopherol less than
300 micrograms/dl) at diagnosis has been implicated as one nutritional
deficiency associated with subsequent lower cognitive stores.
Vitamin K is present in the brain and has a role in the brain growth
receptor system.The Body stores very little vitamin K. In fact, Vitamin k
is rapidly depleted without regular dietary intake. Even the adult hepatic
storage pool, measured by Shearer , is surprisingly small 1.7 to 38.3
micrograms (median 7.8 micrograms).In a child with cystic fibrosis, it is
conceivable that Vitamin K deficiency not only would accompany other
deficiencies of nutrition, but might be one of the first deficiencies to
occur?
In summary,I commend the authors for this important work. Vitamin K has
been associated with bone health, and cystic fibrosis with stunted growth.
I believe the Leeds group provides more data to support the screening of
newborns for cystic fibrosis.
References:
1. Koscik RL, Farrell PM, Kosorok MR, Zaremba,KM, Laxova A, Lai,H-C,
Douglas,JA, Rock MJ, Splaingard,ML. Cognitive function of children with
cystic fibrosis: deleterious effect of early malnutrition.Pediatrics. 2004
Jun;113(6):1549-58.
2. Davidson RT, Foley AL, Engelke JA, Suttie JW. Conversion of dietary
phylloquinone to tissue menaquinone-4 in rats is not dependent on gut
bacteria. Nutrient Metabolism-Research Communication. Manuscript October
27, 1997:220-223.
3.Tsaioun KI. Vitamin K-dependent proteins in the developing and aging
nervous system. Nutr Rev. 1999;57 :231 –240[ISI][Medline]
4.Ferland G. The vitamin K-dependent proteins: an update. Nutr Rev.
1998;56 :223 –230[ISI][Medline]
5.Li J, Lin JC, Wang H, et al. Novel role of vitamin K in preventing
oxidative injury to developing oligodendrocytes and neurons. J Neurosci.
2003;23 :5816 –5826[Abstract/Free Full Text]
6. Carrie I, Portoukalian J, Vicaretti R et al Menaquinone-4concentration
is correlated with sphingolipid
concentrations in rat brain. J Nutr. 2004 Jan;134(1): 167-72
7.Costakos DT, Greer FR, Love LA, Dahlen LR, Sutte JW. Vitamin K
prophylaxis for premature infants: 1 mg versus 0.5 mg. Am J Perinatol.
2003;20 :485 –490[ISI][Medline]
Conflict of Interest:
None declared |
| |
|